hers semaglutide fda 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Hims & Hers stock falls

Chen R, Hollborn M, Grosche A, Reichenbach A, Wiedemann P, Bringmann A, et al

Direct-to-consumer telehealth companies have grown rapidly in response to patients demand for GLP-1s like semaglutide and tirzepatide, especially after shortages created a market for compounded versions that arent approved by the Food and Drug Administration

Coskun T et al

Visual inspection alone cannot detect all forms of chemical degradation strict adherence to validated storage conditions and beyond-use dates is essential

Pill to pen Start once-weekly Wegovy 2.4 mg pen the day after the last dose of once-daily Wegovy pill 25 mg

Blurry vision related to blood glucose stabilization typically resolves within 6-8 weeks as glucose levels stabilize